|
1
|
O'Sullivan JW, Muntinga T, Grigg S and
Ioannidis JPA: Prevalence and outcomes of incidental imaging
findings: Umbrella review. BMJ. 361(k2387)2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Poiană C, Chiriţă C, Carşote M, Hortopan
D, Ioachim D, Corneci CM and Stănescu B: Adrenal and pituitary
incidentalomas in a case of Cushing's syndrome. Chirurgia (Bucur).
108:886–891. 2013.PubMed/NCBI
|
|
3
|
Gheorghisan-Galateanu AA, Carsote M and
Valea A: Incidentaloma: From general practice to specific endocrine
frame. J Pak Med Assoc. 67:917–922. 2017.PubMed/NCBI
|
|
4
|
Booth TC: Incidental findings on imaging.
BMJ. 361(k2611)2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Lumbreras B, Donat L and Hernández-Aguado
I: Incidental findings in imaging diagnostic tests: A systematic
review. Br J Radiol. 83:276–289. 2010.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Canadian Institute for Health Information
(CIHI): Medical Imaging in Canada. CIHI, Ottawa, ON, 2013.
https://www.cihi.ca/en/access-data-and-reports.
Accessed June 21, 2021.
|
|
7
|
Iliesiu A, Ungureanu IA, Petca A,
Constantin MM, Petca RC, Sandru F, Constantin T and Dumitrascu MC:
Paraganglioma presenting as a mesenteric cystic mass: A case
report. Exp Ther Med. 20:2489–2492. 2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Gheorghiu ML, Hortopan D, Dumitrascu A,
Caragheorgheopol A, Stefanescu A, Trifanescu R, Niculescu DA, Baciu
I, Carsote M, Poiana C, et al: Age-related endocrine tumors:
Non-functioning adrenal tumors as compared to pituitary adenomas.
Acta Endo (Buc). 5:371–384. 2009.
|
|
9
|
Soultati A, Alexopoulou A, Dourakis SP,
Dimopoulou H, Katsaounis P, Cokkinos D and Archimandritis AJ: The
burden of incidental findings in clinical practice in a tertiary
care center. Eur J Intern Med. 21:123–126. 2010.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Castleman B, Iverson L and Menendez VP:
Localized mediastinal lymphnode hyperplasia resembling thymoma.
Cancer. 9:822–830. 1956.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Simpson D: Epidemiology of Castleman
disease. Hematol Oncol Clin North Am. 32:1–10. 2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Keller AR, Hochholzer L and Castleman B:
Hyaline-vascular and plasma-cell types of giant lymph node
hyperplasia of the mediastinum and other locations. Cancer.
29:670–683. 1972.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Soumerai JD, Sohani AR and Abramson JS:
Diagnosis and management of Castleman disease. Cancer Contr.
21:266–278. 2014.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Munshi N, Mehra M, van de Velde H, Desai
A, Potluri R and Vermeulen J: Use of a claims database to
characterize and estimate the incidence rate for Castleman disease.
Leuk Lymphoma. 56:1252–1260. 2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Talat N, Belgaumkar AP and Schulte KM:
Surgery in Castleman's disease: A systematic review of 404
published cases. Ann Surg. 255:677–684. 2012.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Szalat R and Munshi NC: Diagnosis of
Castleman disease. Hematol Oncol Clin North Am. 32:53–64.
2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Wong RSM: Unicentric Castleman disease.
Hematol Oncol Clin North Am. 32:65–73. 2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Fujimoto S, Koga T, Kawakami A, Kawabata
H, Okamoto S, Mizuki M, Yano S, Ide M, Uno K, Yagi K, et al:
Tentative diagnostic criteria and disease severity classification
for Castleman disease: A report of the research group on Castleman
disease in Japan. Mod Rheumatol. 28:161–167. 2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
van Rhee F, Greenway A and Stone K:
Treatment of idiopathic Castleman disease. Hematol Oncol Clin North
Am. 32:89–106. 2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Nishimoto N, Kanakura Y, Aozasa K, Johkoh
T, Nakamura M, Nakano S, Nakano N, Ikeda Y, Sasaki T, Nishioka K,
et al: Humanized anti-interleukin-6 receptor antibody treatment of
multicentric Castleman disease. Blood. 106:2627–2632.
2005.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Estephan FF, Elghetany MT, Berry M and
Jones DV Jr: Complete remission with anti-CD20 therapy for
unicentric, non-HIV-associated, hyaline-vascular type, Castleman's
disease. Cancer Invest. 23(191)2005.PubMed/NCBI
|
|
22
|
Oksenhendler E, Boutboul D, Fajgenbaum D,
Mirouse A, Fieschi C, Malphettes M, Vercellino L, Meignin V, Gérard
L and Galicier L: The full spectrum of Castleman disease: 273
patients studied over 20 years. Br J Haematol. 180:206–216.
2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
van Rhee F, Stone K, Szmania S, Barlogie B
and Singh Z: Castleman disease in the 21st century: An update on
diagnosis, assessment, and therapy. Clin Adv Hematol Oncol.
8:486–498. 2010.PubMed/NCBI
|
|
24
|
Hwang MR, Chang HJ, Kim MJ, Seo GJ, Yoo
SB, Park JW, Choi HS and Oh JH: Castleman's disease of the
mesorectum: Report of a case. Surg Today. 41:271–275.
2011.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Yu G, Cao F, Gong H, Liu P, Sun G and
Zhang W: Embolization of blood-supply artery followed by surgery
for treatment of mesorectal Castleman's disease: Case report and
literature review. Gastroenterol Rep (Oxf). 7:141–145.
2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Saeed-Abdul-Rahman I and Al-Amri AM:
Castleman disease. Korean J Hematol. 47:163–177. 2012.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Miulescu R, Balaban DV, Sandru F and Jinga
M: Cutaneous manifestations in pancreatic diseases-a review. J Clin
Med. 9(2611)2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Sandru F, Carsote M, Valea A, Albu SE,
Petca RC and Dumitrascu MC: Somatostatinoma: Beyond
neurofibromatosis type 1 (Review). Exp Ther Med. 20:3383–3388.
2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Ristescu I, Pintilie G, Filip D, Jitca M,
Fecheta R, Florescu I, Scripcariu V, Filipescu D and Grigoraş I:
Perioperative anemia and transfusion in colorectal cancer patients.
Chirurgia (Bucur). 114:234–242. 2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Moran B and Heald RJ (eds): Manual of
Mesorectal Total Excision. 1st edition. CRC Press, Taylor &
Francis Group, Boca Raton, FL, 2013.
|
